loading

MAIA Biotechnology Inc Borsa (MAIA) Ultime notizie

pulisher
Dec 17, 2025

MAIA Biotechnology announces $2.25M private placement deal - MSN

Dec 17, 2025
pulisher
Dec 17, 2025

MAIA Biotechnology Announces $2.25M Private Placement Deal - TipRanks

Dec 17, 2025
pulisher
Dec 17, 2025

MAIA Biotechnology (NYSE American: MAIA) details $2.25M private placement - Stock Titan

Dec 17, 2025
pulisher
Dec 16, 2025

MAIA Biotechnology Announces $1.51 Million Private Placement - The Manila Times

Dec 16, 2025
pulisher
Dec 15, 2025

MAIA Biotechnology, Inc. announced that it expects to receive $1.289791 million in funding - marketscreener.com

Dec 15, 2025
pulisher
Dec 11, 2025

MAIA Biotechnology Announces Significant Insider Buying - TipRanks

Dec 11, 2025
pulisher
Dec 11, 2025

MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets

Dec 11, 2025
pulisher
Dec 11, 2025

MAIA Biotechnology (NYSE: MAIA) starts Ateganosine Phase 3 trial and notes insider buying - Stock Titan

Dec 11, 2025
pulisher
Dec 11, 2025

MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

MAIA Biotechnology (MAIA) doses first patient in THIO-104 Phase 3 NSCLC trial - Stock Titan

Dec 11, 2025
pulisher
Dec 11, 2025

MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - Yahoo Finance

Dec 11, 2025
pulisher
Dec 11, 2025

MAIA Biotechnology announces significant insider buying - MSN

Dec 11, 2025
pulisher
Dec 10, 2025

MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks

Dec 10, 2025
pulisher
Dec 10, 2025

MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView — Track All Markets

Dec 10, 2025
pulisher
Dec 10, 2025

MAIA Biotechnology (NYSE: MAIA) highlights $50B immunotherapy market in press release - Stock Titan

Dec 10, 2025
pulisher
Dec 10, 2025

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - The Manila Times

Dec 10, 2025
pulisher
Dec 10, 2025

Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - setenews.com

Dec 10, 2025
pulisher
Dec 10, 2025

MAIA Biotechnology (NYSE American: MAIA) starts Phase 3 telomere drug trial in NSCLC - Stock Titan

Dec 10, 2025
pulisher
Dec 09, 2025

Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks

Dec 09, 2025
pulisher
Dec 09, 2025

Dir Smith Buys 13,740 ($16.4K) Of Maia Biotechnology Inc [MAIA] - TradingView — Track All Markets

Dec 09, 2025
pulisher
Dec 05, 2025

Can MAIA Biotechnology Inc. stock sustain revenue momentum2025 Price Targets & Real-Time Price Movement Reports - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How MAIA Biotechnology Inc. stock reacts to bond yieldsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Australia

Dec 04, 2025
pulisher
Dec 04, 2025

Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Is MAIA Biotechnology Inc. stock among top earnings plays2025 Stock Rankings & Daily Chart Pattern Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How MAIA Biotechnology Inc. stock compares with top peersMarket Trend Summary & Fast Gain Swing Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares - Investing.com Canada

Dec 04, 2025
pulisher
Dec 04, 2025

Why hedge funds are buying MAIA Biotechnology Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

MAIA Biotechnology Inc (MAIA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com

Dec 03, 2025
pulisher
Dec 03, 2025

How MAIA Biotechnology Inc. stock responds to policy changesTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Will MAIA Biotechnology Inc. stock return to pre crash levels2025 Bull vs Bear & Smart Allocation Stock Reports - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

How MAIA Biotechnology Inc. stock compares with market leaders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Will MAIA Biotechnology Inc. stock recover faster than industryAnalyst Upgrade & Safe Entry Zone Tips - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Why MAIA Biotechnology Inc. stock could rally stronglyJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Top Executives Make Bold Moves with Major Stock Purchases at MAIA Biotechnology! - TipRanks

Dec 02, 2025
pulisher
Dec 01, 2025

MAIA SEC FilingsMAIA Biotechnology Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 01, 2025
pulisher
Dec 01, 2025

Maia Biotechnology announces open market purchases by CEO and directors - marketscreener.com

Dec 01, 2025
pulisher
Dec 01, 2025

MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - The Manila Times

Dec 01, 2025
pulisher
Dec 01, 2025

Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 By Investing.com - Investing.com Australia

Dec 01, 2025
pulisher
Dec 01, 2025

Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares By Investing.com - Investing.com South Africa

Dec 01, 2025
pulisher
Dec 01, 2025

Smith Stan, MAIA Biotechnology director, buys $15,582 in shares By Investing.com - Investing.com South Africa

Dec 01, 2025
pulisher
Dec 01, 2025

Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 - Investing.com India

Dec 01, 2025
pulisher
Dec 01, 2025

Smith Stan, MAIA Biotechnology director, buys $15,582 in shares - Investing.com

Dec 01, 2025
$38.44
price up icon 0.38%
$97.55
price down icon 0.15%
$31.56
price down icon 0.57%
$91.78
price down icon 0.00%
biotechnology ONC
$308.56
price up icon 0.67%
$165.08
price down icon 16.91%
Capitalizzazione:     |  Volume (24 ore):